Hydrolyzable fluorescent substrates and analytical determinations using same

• US 4,812,409 A
• Filed: 01/31/1986
• Issued: 03/14/1989
• Est. Priority Date: 01/31/1986
• Status: Expired due to Term

• Current Assignee: Clinical Diagnostic Systems Inc.
• Original Assignee: Eastman Kodak Company
• Inventors: Belly, Robert T., Scensny, Patricia M., Babb, Bruce E.
• Primary Examiner(s): Rosen, Sam
• Application Number:
  US06/824,756
• Time in Patent Office: 1,138 Days
• Field of Search: 435/7, 435/18, 435/29, 435/38, 435/4, 568/326, 536/1.1, 530/322, 436/800, 260/502.5 R, 558/210
• US Class Current: 435/7.32
• CPC Class Codes: C09B 3/00 Dyes with an anthracene nucleus condensed with one or more carbocyclic rings
• CPC Class Codes: C09B 57/00 Other synthetic dyes of known constitution
• CPC Class Codes: C12Q 1/44 involving esterase
• CPC Class Codes: C12Q 2334/00 O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases
• CPC Class Codes: G01N 33/52 Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72
• CPC Class Codes: Y10S 436/80 Fluorescent dyes, e.g. rhodamine

Abstract

Hydrolyzable substrates comprise blocked dye moieties which, when cleaved from the substrate during hydrolysis, provide fluorescent dyes having maximum absorptions above about 530 nm and maximum emissions at least about 580 nm at physiological pH. These substrates can be used in analytical determinations of hydrolytic substances including hydrolytic enzymes or biological cells containing such enzymes.

Claims

1. A hydrolyzable compound represented by the formula:

space="preserve" listing-type="equation">BLOCK--X--R.sup.f --L

wherein BLOCK is a hydrolyzable group selected from the group consisting of;

--COR¹ ;

a monovalent moiety derived by removal of a hydroxy group from a carboxy group of an amino acid or peptide;

or a monovalent moiety derived by removal of a hydroxy group from a mono- or polysaccharide,

R¹ is hydrogen, alkyl, alkenyl, aryl, cycloalkyl or a heterocyclic group,

X is --O--, --S-- or --NR-- and is attached to BLOCK at the open valence on BLOCK wherein R is hydrogen, alkyl, cycloalkyl, phenyl or a heterocyclic group,

R^f is a phenalenone or benzphenalenone fluorescent moiety selected from the group consisting essentially of ##STR6## provided that when released as --X--R^f --L, --X--R^f --L exhibits maximum fluorescent emission at least about 580 nm at a pH of 9 or less, and L is hydrogen or a specific binding ligand.

2. The compound of claim 1 wherein BLOCK is --CO--R¹ wherein R¹ is hydrogen or alkyl.

3. The compound of claim 1 wherein L is hydrogen.

4. The compound of claim 1 wherein L is a specific binding ligand.

5. The compound of claim 1 wherein X is --O-- or --NR--.

6. An analytical composition comprising an solution buffered to a pH of 9 or less and containing a hydrolyzable compound represented by the formula:

space="preserve" listing-type="equation">BLOCK--X--R.sup.f --L

wherein BLOCK is a hydrolyzable group selected from the group consisting of;

--COR¹ ;

a monovalent moiety derived by removal of a hydroxy group from a carboxy group of an amino acid or peptide;

or a monovalent moiety derived by removal of a hydroxy group from a mono- or polysaccharide,

R¹ is hydrogen, alkyl, alkenyl, aryl, cycloalkyl or a heterocyclic group,

X is --O--, --S-- or --NR-- and is attached to BLOCK at the open valence on BLOCK, wherein R is hydrogen, alkyl, cycloalkyl, phenyl or a heterocyclic group,

R^f is a phenalenone or benzphenalenone fluorescent moiety selected from the group consisting essentially of ##STR7## provided that when released as --X--R^f --L, --X--R^f --L exhibits maximum fluorescent emission at least about 580 nm and maximum absorption above about 540 nm at a pH of 9 or less, and L is hydrogen or a specific binding ligand.

7. The composition of claim 6 further comprising a water-miscible solvent and a surfactant.

8. The composition of claim 6 wherein BLOCK is --CO--R¹ wherein R¹ is independently hydrogen or alkyl, L is hydrogen and X is --O-- or --NR--.

9. An analytical element comprising an absorbent carrier material and containing a hydrolyzable compound represented by the formula:

space="preserve" listing-type="equation">BLOCK--X--R.sup.f --L

wherein BLOCK is a hydrolyzable group selected from the group consisting of;

--COR¹ ;

a monovalent moiety derived by removal of a hydroxy group from a carboxy group of an amino acid or peptide;

or a monovalent moiety derived by removal of a hydroxy group from a mono- or polysaccharide,

R¹ is hydrogen, alkyl, alkenyl, aryl, cycloalkyl or a heterocyclic group,

X is --O--, --S-- or --NR-- and is attached to BLOCK at the open valence on BLOCK, wherein R is hydrogen, alkyl, cycloalkyl, phenyl or a heterocyclic group,

R^f is a phenalenone or benzphenalenone fluorescent moiety selected from the group consisting essentially of ##STR8## provided that when released as --X--R^f --L, --X--R^f --L exhibits maximum fluorescent emission at least about 580 nm and maximum absorption above about 530 nm at a pH of 9 or less, and L is hydrogen or a specific binding ligand.

10. The element of claim 9 further containing a buffer which maintains the pH at 9 or less during an assay.

11. The element of claim 9 comprising a nonporous support having therein a porous spreading zone as said absorbent carrier material.

12. The element of claim 9 wherein BLOCK is --CO--R¹ wherein R¹ is hydrogen or alkyl, L is hydrogen, and X is --O-- or --NR--.

13. A method for the determination of a hydrolytic analyte comprising the steps of:

A. under hydrolyzing conditions, contacting a sample of a liquid suspected of containing a hydrolytic analyte with a hydrolyzable compound represented by the formula;

space="preserve" listing-type="equation">BLOCK--X--R.sup.f --L

wherein BLOCK is a hydrolyzable group selected from the group consisting of;

--COR¹ ;

a monovalent moiety derived by removal of a hydroxy group from a carboxy group of an amino acid or peptide;

or a monovalent moiety derived by removal of a hydroxy group from a mono- or polysaccharide,

R¹ is hydrogen, alkyl, alkenyl, aryl, cycloalkyl or a heterocyclic group,

X is --O--, --S-- or --NR-- and is attached to BLOCK at the open valence on BLOCK, wherein R is hydrogen, alkyl, cycloalkyl, phenyl or a heterocyclic group,

R^f is a phenalenone or benzphenalenone fluorescent moiety selected from the group consisting essentially of ##STR9## provided that when released as --X--R^f --L, --X--R^f --L exhibits maximum fluorescent emission at least about 580 nm and maximum absorption above about 530 nm at a pH of 9 or less, and L is hydrogen or a specific binding ligand, and

B. determining the fluorescent moiety released from said compound by hydrolysis as a result of the presence of said hydrolytic analyte at a wavelength at least about 580 nm after excitation at a wavelength above about 530 nm.

14. The method of claim 13 carried out at a pH of 8 or less.

15. The method of claim 13 for the determination of a hydrolytic enzyme.

16. The method of claim 13 which is a competitive binding assay.

17. The method of claim 13 wherein BLOCK is --CO--R¹ wherein R¹ is hydrogen or alkyl, L is hydrogen, and X is --O-- or --NR--.

18. The method of claim 13 for the determination of Klebsiella pneumoniae or Enterobacter cloacae wherein BLOCK is derived from a monosaccharide.